The COVID-19 coronavirus pandemic has forced a massive shift in businesses across the board and this is especially true for
1933 Industries (TGIF) (
CSE:TGIF,
OTCQX: TGIFF,
Forum), who reported that during its
Q3 2020, its revenues were adversely impacted by closures in Nevada related to the virus, resulting in significantly lower-than-expected sales across the Company’s product lines, in particular its
Alternative Medicine Association (AMA)-branded flower and concentrates business line.
That hasn’t deterred this vertically integrated cannabis consumer packaged goods Company, who just kicked of a non-brokered financing of up to
$5 million (CAD).
Focusing on cultivation and manufacturing in a wide range of product formats, TGIF controls all aspects of its value chain with cultivation, extraction, processing, and manufacturing assets supporting its diversified portfolio of cannabis brands and licensing partners. This includes the Company’s award-winning proprietary portfolio of brands: AMA flower and concentrates as well as CBD-infused Canna Hemp™, Canna Hemp X™, and Canna Fused™ products.
Stockhouse Editorial recently caught up with Paul Rosen, who was appointed 1933 Industries’
interim CEO in June, to talk about the Company’s focus on accelerating growth and profitability.
(Click image to play video podcast)
To find out more about TGIF, visit their website at
https://www.1933industries.com/
FULL DISCLOSURE: This is a paid article produced by Stockhouse Publishing.